Literature DB >> 1374630

Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEpo) in severe aplastic anaemia.

M Bessho1, A Toyoda, Y Itoh, T Sakata, N Kawai, I Jinnai, M Saito, K Hirashima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1374630     DOI： 10.1111/j.1365-2141.1992.tb08154.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Long-term follow-up of patients with aplastic anemia and refractory anemia responding to combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin.

Authors:  Akira Matsuda; Kuniya Kishimoto; Katsuhiko Yoshida; Fumiharu Yagasaki; Yoshihiro Ito; Tohru Sakata; Nobutaka Kawai; Hirohide Ino; Kunitake Hirashima; Masami Bessho
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

2.  Haematological improvement by long-term administration of recombinant human granulocyte-colony stimulating factor and recombinant human erythropoietin in a patient with severe aplastic anaemia.

Authors:  J Nawata; Y Toyoda; H Nisihira; K Honda; H Kigasawa; T Nagao
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

3.  Failure of combination therapy with recombinant granulocyte colony-stimulating factor and erythropoietin in myelodysplastic syndromes.

Authors:  M Imamura; M Kobayashi; S Kobayashi; K Yoshida; C Mikuni; Y Ishikawa; S Matsumoto; S Sakamaki; Y Niitsu; Y Hinoda
Journal:  Ann Hematol       Date:  1994-04       Impact factor: 3.673
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.